APA (7th ed.) Citation

HJ, L., SI, W., WS, H., FS, F., & JC, W. (2025). Association between novel agents targeting proprotein convertase subtilisin/kexin type 9 and cancer incidence. Naunyn-Schmiedeberg's archives of pharmacology, 398(11), 16241. https://doi.org/10.1007/s00210-025-04332-3

Chicago Style (17th ed.) Citation

HJ, Lu, Wang SI, Huang WS, Fan FS, and Wei JC. "Association Between Novel Agents Targeting Proprotein Convertase Subtilisin/kexin Type 9 and Cancer Incidence." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 11 (2025): 16241. https://doi.org/10.1007/s00210-025-04332-3.

MLA (9th ed.) Citation

HJ, Lu, et al. "Association Between Novel Agents Targeting Proprotein Convertase Subtilisin/kexin Type 9 and Cancer Incidence." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 11, 2025, p. 16241, https://doi.org/10.1007/s00210-025-04332-3.